Clinical Trial Update: Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating duloxetine for predominant stress urinary incontinence has completed; the snippet does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence
• Urinary Incontinence

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Urinary Incontinence, Stress | Phase 3 | Status: COMPLETED